PL3645518T3 - Synteza omekamtywu mekarbilu - Google Patents
Synteza omekamtywu mekarbiluInfo
- Publication number
- PL3645518T3 PL3645518T3 PL18743314T PL18743314T PL3645518T3 PL 3645518 T3 PL3645518 T3 PL 3645518T3 PL 18743314 T PL18743314 T PL 18743314T PL 18743314 T PL18743314 T PL 18743314T PL 3645518 T3 PL3645518 T3 PL 3645518T3
- Authority
- PL
- Poland
- Prior art keywords
- synthesis
- omecamtiv mecarbil
- mecarbil
- omecamtiv
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- RFUBTTPMWSKEIW-UHFFFAOYSA-N omecamtiv mecarbil Chemical compound C1CN(C(=O)OC)CCN1CC1=CC=CC(NC(=O)NC=2C=NC(C)=CC=2)=C1F RFUBTTPMWSKEIW-UHFFFAOYSA-N 0.000 title 1
- 229950001617 omecamtiv mecarbil Drugs 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/205—Radicals derived from carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762527174P | 2017-06-30 | 2017-06-30 | |
| US201862664363P | 2018-04-30 | 2018-04-30 | |
| PCT/US2018/040176 WO2019006231A1 (en) | 2017-06-30 | 2018-06-29 | SYNTHESIS OF OMECAMTIV MECARBIL |
| EP18743314.9A EP3645518B1 (en) | 2017-06-30 | 2018-06-29 | Synthesis of omecamtiv mecarbil |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3645518T3 true PL3645518T3 (pl) | 2021-12-06 |
Family
ID=62976317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL18743314T PL3645518T3 (pl) | 2017-06-30 | 2018-06-29 | Synteza omekamtywu mekarbilu |
Country Status (30)
| Country | Link |
|---|---|
| US (4) | US11040956B2 (pl) |
| EP (3) | EP3925950B1 (pl) |
| JP (2) | JP7181896B2 (pl) |
| KR (1) | KR102625774B1 (pl) |
| CN (1) | CN110799503B (pl) |
| AU (2) | AU2018294254C1 (pl) |
| BR (1) | BR112019028205A2 (pl) |
| CA (1) | CA3063102A1 (pl) |
| CL (2) | CL2019003898A1 (pl) |
| CY (1) | CY1124427T1 (pl) |
| DK (1) | DK3645518T3 (pl) |
| ES (1) | ES2882905T3 (pl) |
| GE (5) | GEAP202115258A (pl) |
| HR (1) | HRP20211290T1 (pl) |
| HU (1) | HUE055242T2 (pl) |
| IL (2) | IL270663B (pl) |
| LT (1) | LT3645518T (pl) |
| MD (1) | MD3645518T2 (pl) |
| MX (3) | MX2021009594A (pl) |
| PH (1) | PH12019502883A1 (pl) |
| PL (1) | PL3645518T3 (pl) |
| PT (1) | PT3645518T (pl) |
| RS (1) | RS62328B1 (pl) |
| SG (1) | SG10202111790YA (pl) |
| SI (1) | SI3645518T1 (pl) |
| SM (1) | SMT202100472T1 (pl) |
| TW (2) | TWI769272B (pl) |
| UA (1) | UA127517C2 (pl) |
| WO (1) | WO2019006231A1 (pl) |
| ZA (1) | ZA202000534B (pl) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS53600B1 (sr) | 2004-06-17 | 2015-02-27 | Cytokinetics, Inc. | Jedinjenja, preparati i metode |
| AU2014240049C1 (en) | 2013-03-14 | 2019-03-07 | Amgen Inc. | Heterocyclic compounds and their uses |
| FI3645002T3 (fi) | 2017-06-30 | 2025-01-29 | Amgen Inc | Menetelmiä sydämen vajaatoiminnan hoitamiseksi sydämen sarkomeerin aktivaattoreilla |
| UA127517C2 (uk) | 2017-06-30 | 2023-09-20 | Емджен Інк. | Синтез омекамтиву мекарбілу |
| WO2019055590A1 (en) | 2017-09-13 | 2019-03-21 | Amgen Inc. | SARCOMERIC BISAMIDE ACTIVATOR COMPOUNDS AND USES THEREOF |
| DK3594199T3 (da) | 2018-07-09 | 2020-09-14 | Fis Fabbrica Italiana Sintetici Spa | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf |
| AU2019321573B2 (en) | 2018-08-17 | 2025-05-29 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
| US12442027B2 (en) | 2018-12-18 | 2025-10-14 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| US20220402874A1 (en) * | 2019-10-09 | 2022-12-22 | Dr. Reddy's Laboratories Limited | Solid forms of omecamtiv mecarbil dihydrochloride and processes thereof |
| US20220411374A1 (en) * | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
| PL4243825T3 (pl) | 2020-11-12 | 2026-03-23 | Amgen Inc. | Omecamtiv mecarbil w leczeniu niewydolności serca u wybranych grup pacjentów |
| JP2024509797A (ja) | 2021-03-10 | 2024-03-05 | アムジェン インコーポレイテッド | オメカムチブメカルビルの合成 |
| WO2023205291A2 (en) * | 2022-04-21 | 2023-10-26 | The Board Of Regents Of The University Of Oklahoma | Targeting myocardial tissue for delivery of therapeutic and imaging agents |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5580872A (en) | 1990-05-02 | 1996-12-03 | Abbott Laboratories | Quinolizinone type compounds |
| US6492529B1 (en) * | 2000-01-18 | 2002-12-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Bis pyrazole-1H-pyrazole intermediates and their synthesis |
| RS53600B1 (sr) | 2004-06-17 | 2015-02-27 | Cytokinetics, Inc. | Jedinjenja, preparati i metode |
| US20070208000A1 (en) | 2005-12-15 | 2007-09-06 | Morgan Bradley P | Certain chemical entities, compositions and methods |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| JP5178526B2 (ja) * | 2005-12-19 | 2013-04-10 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
| BRPI0622042A2 (pt) * | 2006-09-25 | 2014-06-10 | Siemens Ag | Produção de contato de barra coletora com compensação de espessura de barra |
| RS51647B (sr) * | 2006-10-18 | 2011-10-31 | Pfizer Products Inc. | Jedinjenja biaril etar uree |
| US20090192168A1 (en) | 2008-01-04 | 2009-07-30 | Alex Muci | Compounds, Compositions and Methods |
| WO2010141817A1 (en) * | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
| HUE046617T2 (hu) | 2010-11-10 | 2020-03-30 | Genentech Inc | Pirazol-aminopirimidin-származékok mint LRRK2 modulátorok |
| CN104271569B (zh) | 2012-05-03 | 2016-08-24 | 霍夫曼-拉罗奇有限公司 | 作为lrrk2调节剂的吡唑氨基嘧啶衍生物 |
| AU2014240049C1 (en) | 2013-03-14 | 2019-03-07 | Amgen Inc. | Heterocyclic compounds and their uses |
| CA2902424A1 (en) | 2013-03-14 | 2014-09-25 | Amgen Inc. | Heterocyclic compounds and their uses |
| KR101885448B1 (ko) | 2014-03-31 | 2018-08-03 | 가부시키가이샤 메테크 | 혈액 정화 장치 및 혈액 정화 장치의 보액·프라이밍 방법 |
| JP6422589B2 (ja) * | 2014-11-24 | 2018-11-14 | メディフロン・ディービーティー・インコーポレイテッド | バニロイド受容体リガンドｉｉとしての置換されたオキサゾール系およびチアゾール系カルボキサミドおよび尿素誘導体 |
| ES3009592T3 (en) | 2015-01-29 | 2025-03-27 | Signal Pharm Llc | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| JP6858716B2 (ja) | 2015-06-26 | 2021-04-14 | アムジエン・インコーポレーテツド | 心筋ミオシン活性化剤と洞房結節Ｉｆ電流阻害剤の併用療法 |
| FI3645002T3 (fi) | 2017-06-30 | 2025-01-29 | Amgen Inc | Menetelmiä sydämen vajaatoiminnan hoitamiseksi sydämen sarkomeerin aktivaattoreilla |
| UA127517C2 (uk) | 2017-06-30 | 2023-09-20 | Емджен Інк. | Синтез омекамтиву мекарбілу |
| DK3594199T3 (da) | 2018-07-09 | 2020-09-14 | Fis Fabbrica Italiana Sintetici Spa | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf |
| AU2019321573B2 (en) | 2018-08-17 | 2025-05-29 | Amgen Inc. | Salts and crystal forms of omecamtiv mecarbil |
| US12442027B2 (en) | 2018-12-18 | 2025-10-14 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| US20220411374A1 (en) | 2019-10-09 | 2022-12-29 | Dr. Reddy's Laboratories Limited | Alternate processes for the preparation of omecamtiv mecarbil |
| EP4103159A1 (en) | 2020-02-10 | 2022-12-21 | Amgen Inc. | Omecamtiv mecarbil tablet |
| PL4243825T3 (pl) | 2020-11-12 | 2026-03-23 | Amgen Inc. | Omecamtiv mecarbil w leczeniu niewydolności serca u wybranych grup pacjentów |
| JP2024509797A (ja) | 2021-03-10 | 2024-03-05 | アムジェン インコーポレイテッド | オメカムチブメカルビルの合成 |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
-
2018
- 2018-06-29 UA UAA202000509A patent/UA127517C2/uk unknown
- 2018-06-29 GE GEAP202115258A patent/GEAP202115258A/en unknown
- 2018-06-29 US US16/607,940 patent/US11040956B2/en active Active
- 2018-06-29 AU AU2018294254A patent/AU2018294254C1/en active Active
- 2018-06-29 PH PH1/2019/502883A patent/PH12019502883A1/en unknown
- 2018-06-29 SI SI201830350T patent/SI3645518T1/sl unknown
- 2018-06-29 RS RS20210965A patent/RS62328B1/sr unknown
- 2018-06-29 PL PL18743314T patent/PL3645518T3/pl unknown
- 2018-06-29 GE GEAP202416116A patent/GEAP202416116A/en unknown
- 2018-06-29 MX MX2021009594A patent/MX2021009594A/es unknown
- 2018-06-29 BR BR112019028205-0A patent/BR112019028205A2/pt active IP Right Grant
- 2018-06-29 DK DK18743314.9T patent/DK3645518T3/da active
- 2018-06-29 EP EP21174262.2A patent/EP3925950B1/en active Active
- 2018-06-29 PT PT187433149T patent/PT3645518T/pt unknown
- 2018-06-29 MD MDE20200486T patent/MD3645518T2/ro unknown
- 2018-06-29 WO PCT/US2018/040176 patent/WO2019006231A1/en not_active Ceased
- 2018-06-29 HU HUE18743314A patent/HUE055242T2/hu unknown
- 2018-06-29 MX MX2019015547A patent/MX387531B/es unknown
- 2018-06-29 SM SM20210472T patent/SMT202100472T1/it unknown
- 2018-06-29 LT LTEP18743314.9T patent/LT3645518T/lt unknown
- 2018-06-29 MX MX2021013326A patent/MX394683B/es unknown
- 2018-06-29 EP EP18743314.9A patent/EP3645518B1/en active Active
- 2018-06-29 KR KR1020207001578A patent/KR102625774B1/ko active Active
- 2018-06-29 GE GEAP201815258A patent/GEP20227340B/en unknown
- 2018-06-29 TW TW107122465A patent/TWI769272B/zh active
- 2018-06-29 GE GEAP202315463A patent/GEP20237530B/en unknown
- 2018-06-29 CA CA3063102A patent/CA3063102A1/en active Pending
- 2018-06-29 CN CN201880043674.6A patent/CN110799503B/zh active Active
- 2018-06-29 ES ES18743314T patent/ES2882905T3/es active Active
- 2018-06-29 JP JP2019561794A patent/JP7181896B2/ja active Active
- 2018-06-29 HR HRP20211290TT patent/HRP20211290T1/hr unknown
- 2018-06-29 GE GEAP201816116A patent/GEP20247675B/en unknown
- 2018-06-29 IL IL270663A patent/IL270663B/en unknown
- 2018-06-29 SG SG10202111790YA patent/SG10202111790YA/en unknown
- 2018-06-29 EP EP23189293.6A patent/EP4265597A3/en active Pending
- 2018-06-29 TW TW111120441A patent/TWI847144B/zh active
- 2018-06-29 IL IL294834A patent/IL294834B2/en unknown
-
2019
- 2019-12-30 CL CL2019003898A patent/CL2019003898A1/es unknown
-
2020
- 2020-01-27 ZA ZA2020/00534A patent/ZA202000534B/en unknown
-
2021
- 2021-05-19 US US17/324,867 patent/US11753394B2/en active Active
- 2021-08-10 CY CY20211100714T patent/CY1124427T1/el unknown
- 2021-08-16 CL CL2021002167A patent/CL2021002167A1/es unknown
-
2022
- 2022-06-29 AU AU2022204648A patent/AU2022204648B2/en active Active
- 2022-08-19 JP JP2022130911A patent/JP7522799B2/ja active Active
-
2023
- 2023-07-26 US US18/359,467 patent/US12269811B2/en active Active
-
2025
- 2025-01-17 US US19/029,945 patent/US20250163023A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273230A (en) | Preparation of carbamoylpyridone-polycyclic compounds | |
| IL272888B1 (en) | Uses of piperidinyl-indole derivatives | |
| SMT202100472T1 (it) | Sintesi di omecamtiv mecarbil | |
| HUE050936T2 (hu) | Heterociklusos vegyületek szintézise | |
| ZA201808057B (en) | Synthesis of indazoles | |
| IL295588A (en) | Synthesis of the Lichondrins | |
| IL262413B (en) | Synthesis of indazoles | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| IL273784A (en) | Synthesis of cantharidin | |
| PT3661491T (pt) | 3-metilmetcatinona para uso no tratamento de um indivíduo sob uma intervenção psicoterapêutica | |
| HUE066451T2 (hu) | Mezotrion szintézise | |
| IL258408B (en) | Improved synthesis of honokiol | |
| GB2544486B (en) | Synthesis of Ammonia | |
| GB201513979D0 (en) | Synthesis of benzodiazepine derivatives | |
| GB201510544D0 (en) | New synthesis of tapentadol-hci intermediates | |
| PL3752507T3 (pl) | Synteza triazolochinozalinonów | |
| GB201807468D0 (en) | Methods of synthesis | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| HK40007680A (en) | N-carboxyanhydride-based-scale synthesis of elamipretide |